Hematology CME

Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Following the Evidence to Effective Therapy for Myelofibrosis: How Clinicians Can Overcome Challenges in Patient Care in the JAK Inhibitor Era
Ruben A. Mesa, MD, FACP
July 14, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Transforming Modern Care in AML: Clinical Solutions With Novel Agents for Diverse Patient Populations
Harry P. Erba, MD, PhD
July 10, 2020
Credits: 1.00 CME / MOC / CPE
Medical Learning Institute, Inc.
Teaming Up to Reduce the Burden of Cancer-Associated VTE: Applying the Latest Guidelines and Evidence in Gastrointestinal and Hematologic Malignancies and Other Cancer Settings
Alok A. Khorana, MD, FACP, FASCO
July 2, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?
Robert D. McBane, MD
June 30, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Transforming Care With BTK Inhibitors in CLL: New Insights on Therapy Selection, Safety, and Agent Sequencing Across the Treatment Continuum
Florence Cymbalista, MD, PhD
June 17, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Fueling Innovation in Multiple Myeloma: Thoughts From the Chair
Sagar Lonial, MD, FACP
June 16, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Advances in AML Care: Highlights From Recent Science
Harry P. Erba, MD, PhD
June 15, 2020
Credits: 0.50 CME / MOC / CPE
Medical Learning Institute, Inc.
Chair’s Take on Cancer-Associated VTE: Highlights From Recent Science
Alok A. Khorana, MD, FACP, FASCO
June 11, 2020
Credits: 0.75 CME
Medical Learning Institute, Inc.
Achieving Consensus on Modern VOD/SOS Management: A Guide to Disease Recognition, Classification, and Treatment in Adults and Pediatric Patients
Mitchell S. Cairo, MD
June 4, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency
Robin Lachmann, MD, PhD / Melissa Wasserstein, MD
June 3, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Purdue University
Biosimilars as Partners in Oncology: Expert Guidance on Understanding and Incorporating Biosimilar Agents in Real-World Care
Hope S. Rugo, MD, FASCO
April 28, 2020
University of Florida College of Medicine
Making the Connection: A Call to Action Against Undiagnosed Atrial Fibrillation—Improving Detection, Reducing Risk
Christian T. Ruff, MD, MPH
March 27, 2020
The Medical College of Wisconsin
State-of-the-Art Solutions for Myelofibrosis: The Intersection of JAK Inhibitors, Allogeneic Transplant, and Other Strategies for Patient Care
Prithviraj Bose, MD
March 23, 2020
The Medical College of Wisconsin
Taking the Leap With CAR T: Opportunities for Improving Care and Optimizing Cell Therapy in Hematologic Cancers
Michael R. Bishop, MD
March 12, 2020
Penn State College of Medicine
Expanding Options for Prophylaxis and Treatment of Acute and Chronic GVHD: Mapping the Path to Better Patient Outcomes in Post-Transplant Care
Miguel-Angel Perales, MD
December 31, 2019
Medical Learning Institute, Inc.
Exploring Emerging Strategies in the Management of Anemia in Chronic Kidney Disease
Jay B. Wish, MD
December 31, 2019
Medical Learning Institute, Inc.
How I Think, How I Treat: BTK Inhibitors as a Clinical Strategy in CLL, MCL, and Beyond—Therapeutic Selection, Sequencing, and Next Steps
Andre H. Goy, MD
December 30, 2019
Medical Learning Institute, Inc.
Recognizing and Managing Hemophilia in the Emergency Department in an Era of Expanding Therapeutic Options: A Progress-in-Practice MasterClass and Practicum
Sarah Luisa Melendez, MD / Doris Quon, MD, PhD
December 2, 2019
Penn State College of Medicine
Driving Change in Multiple Myeloma: Updates on Novel Agent Classes and Next-Generation Therapeutics
Robert Z. Orlowski, MD, PhD
August 8, 2019

Pages